COVID-19 has boosted the interest and need of an expenditure analysis by disease. The approach to generate this data has been tested and gained experience from studies over the last 50 years. Not only can COVID-19 decisions related be improved, but many noncommunicable diseases. Efficient allocation and use of resources can be improved by a transparent and informed process. As every country has a particular mix of health system structure, needs, use of resources and policy priorities, the estimation of expenditure by disease is not only a country-specific activity, but also guided by the same standard set of principles. |